N-(2-tert-butyl-5-phenylphenyl)-N-spiro[cyclohexane-1,9'-fluorene]-2'-yldibenzofuran-3-amine
C46H41NO — CID 176781228
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(2-tert-butyl-5-phenylphenyl)-N-spiro[cyclohexane-1,9'-fluorene]-2'-yldibenzofuran-3-amine
N-(2-tert-butyl-5-phenylphenyl)-N-spiro[cyclohexane-1,9'-fluorene]-2'-yldibenzofuran-3-amine (PubChem CID 176781228) has the molecular formula C46H41NO and a molecular weight of 623.84 g/mol. Its IUPAC name is N-(2-tert-butyl-5-phenylphenyl)-N-spiro[cyclohexane-1,9'-fluorene]-2'-yldibenzofuran-3-amine.
Molecular Properties
| Compound Name | N-(2-tert-butyl-5-phenylphenyl)-N-spiro[cyclohexane-1,9'-fluorene]-2'-yldibenzofuran-3-amine |
|---|---|
| PubChem CID | 176781228 |
| Molecular Formula | C46H41NO |
| Molecular Weight | 623.84 g/mol |
| Exact Mass | 623.32 |
| IUPAC Name | N-(2-tert-butyl-5-phenylphenyl)-N-spiro[cyclohexane-1,9'-fluorene]-2'-yldibenzofuran-3-amine |
| SMILES | CC(C)(C)c1ccc(-c2ccccc2)cc1N(c1ccc2c(c1)C1(CCCCC1)c1ccccc1-2)c1ccc2c(c1)oc1ccccc12 |
| InChI | InChI=1S/C46H41NO/c1-45(2,3)40-25-20-32(31-14-6-4-7-15-31)28-42(40)47(34-22-24-38-37-17-9-11-19-43(37)48-44(38)30-34)33-21-23-36-35-16-8-10-18-39(35)46(41(36)29-33)26-12-5-13-27-46/h4,6-11,14-25,28-30H,5,12-13,26-27H2,1-3H3 |
| InChIKey | QQTUSAHMDABQNX-UHFFFAOYSA-N |
| XLogP | 13.25 |
| TPSA | 16.38 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 48 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 623.84 |
| LogP ≤ 5 | 13.25 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176781228 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.